Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1992 1
1993 3
1995 3
1996 1
1997 3
1998 1
1999 3
2000 1
2003 1
2004 1
2005 1
2007 1
2008 3
2009 1
2010 3
2011 5
2012 7
2013 8
2014 5
2015 5
2016 4
2017 3
2019 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M. Fangusaro J, et al. Among authors: jakacki ri. Lancet Oncol. 2019 Jul;20(7):1011-1022. doi: 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. Lancet Oncol. 2019. PMID: 31151904 Free PMC article. Clinical Trial.
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
Banerjee A, Jakacki RI, Onar-Thomas A, Wu S, Nicolaides T, Young Poussaint T, Fangusaro J, Phillips J, Perry A, Turner D, Prados M, Packer RJ, Qaddoumi I, Gururangan S, Pollack IF, Goldman S, Doyle LA, Stewart CF, Boyett JM, Kun LE, Fouladi M. Banerjee A, et al. Among authors: jakacki ri. Neuro Oncol. 2017 Aug 1;19(8):1135-1144. doi: 10.1093/neuonc/now282. Neuro Oncol. 2017. PMID: 28339824 Free PMC article. Clinical Trial.
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Jakacki RI, Cohen KJ, Buxton A, Krailo MD, Burger PC, Rosenblum MK, Brat DJ, Hamilton RL, Eckel SP, Zhou T, Lavey RS, Pollack IF. Jakacki RI, et al. Neuro Oncol. 2016 Oct;18(10):1442-50. doi: 10.1093/neuonc/now038. Epub 2016 Mar 22. Neuro Oncol. 2016. PMID: 27006176 Free PMC article. Clinical Trial.
Peptide vaccine therapy for childhood gliomas.
Pollack IF, Jakacki RI, Butterfield LH, Okada H. Pollack IF, et al. Among authors: jakacki ri. Neurosurgery. 2013 Aug;60 Suppl 1:113-9. doi: 10.1227/01.neu.0000430769.33467.68. Neurosurgery. 2013. PMID: 23839362 Review. No abstract available.
Ependymomas: development of immunotherapeutic strategies.
Pollack IF, Jakacki RI, Butterfield LH, Okada H. Pollack IF, et al. Among authors: jakacki ri. Expert Rev Neurother. 2013 Oct;13(10):1089-98. doi: 10.1586/14737175.2013.840420. Expert Rev Neurother. 2013. PMID: 24117271 Free PMC article. Review.
Pseudoprogression of low-grade gliomas after radiotherapy.
Naftel RP, Pollack IF, Zuccoli G, Deutsch M, Jakacki RI. Naftel RP, et al. Among authors: jakacki ri. Pediatr Blood Cancer. 2015 Jan;62(1):35-9. doi: 10.1002/pbc.25179. Epub 2014 Sep 11. Pediatr Blood Cancer. 2015. PMID: 25213668
58 results